Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Shares Outstanding (Diluted Average): 2021-2024

Historic Shares Outstanding (Diluted Average) for Kiniksa Pharmaceuticals International (KNSA) over the last 4 years, with Dec 2024 value amounting to $71.4 million.

  • Kiniksa Pharmaceuticals International's Shares Outstanding (Diluted Average) rose 11.58% to $80.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.0 million, marking a year-over-year increase of 11.58%. This contributed to the annual value of $71.4 million for FY2024, which is 0.69% down from last year.
  • According to the latest figures from FY2024, Kiniksa Pharmaceuticals International's Shares Outstanding (Diluted Average) is $71.4 million, which was down 0.69% from $71.9 million recorded in FY2023.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Shares Outstanding (Diluted Average) ranged from a high of $71.9 million in FY2023 and a low of $68.6 million during FY2021.
  • In the last 3 years, Kiniksa Pharmaceuticals International's Shares Outstanding (Diluted Average) had a median value of $71.4 million in 2024 and averaged $71.3 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first increased by 2.69% in 2022, then dropped by 0.69% in 2024.
  • Over the past 4 years, Kiniksa Pharmaceuticals International's Shares Outstanding (Diluted Average) (Yearly) stood at $68.6 million in 2021, then rose by 2.69% to $70.4 million in 2022, then grew by 2.13% to $71.9 million in 2023, then dropped by 0.69% to $71.4 million in 2024.